A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson’s disease, potentially replacing the need for multiple daily tablets.
Scientists from the University of South Australia (UniSA) have developed a long-acting injectable formulation that delivers a steady dose of levodopa and carbidopa – two key medications for Parkinson’s – over an entire week.
Their findings have been reported in the journal Drug Delivery and Translational Research.
The biodegradable formulation is injected under the skin or into muscle tissue, where it gradually releases the medication over seven days.
Parkinson’s disease is the second most common neurological disorder, affecting more than 8.5 million people worldwide. Currently there is no cure and the symptoms – tremors, rigidity and slow movement – are managed with oral medications that must be taken several times a day.
The frequent dosing is a burden, especially for elderly patients or those with swallowing difficulties, leading to inconsistent medication levels, more side effects, and reduced effectiveness.
Lead researcher Professor Sanjay Garg, from UniSA’s Centre for Pharmaceutical Innovation, says the newly developed injectable could significantly improve treatment outcomes and patient adherence.
Our goal was to create a formulation that simplifies treatment, improves patient compliance, and maintains consistent therapeutic levels of medication. This weekly injection could be a game-changer for Parkinson’s care.
Levodopa is the gold-standard therapy for Parkinson’s, but its short life span means it must be taken several times a day.”
Professor Sanjay Garg, from UniSA’s Centre for Pharmaceutical Innovation
UniSA PhD student Deepa Nakmode says the in-situ implant is designed to release both levodopa and carbidopa steadily over one week, maintaining consistent plasma levels and reducing the risks associated with fluctuating drug concentrations.
The injectable gel combines an FDA-approved biodegradable polymer PLGA with Eudragit L-100, a pH-sensitive polymer, to achieve a controlled and sustained drug release.
Extensive lab tests confirmed the system’s effectiveness and safety:
- More than 90% of the levodopa dose and more than 81% of the carbidopa dose was released over seven days.
- The implant degraded by over 80% within a week and showed no significant toxicity in cell viability tests.
- The formulation can be easily administered through a fine 22-gauge needle, minimising discomfort and eliminating the need for surgical implant.
“The implications of this research are profound,” Prof. Garg says. “By reducing the frequency of dosing from multiple times a day to a weekly injection is a major step forward in Parkinson’s therapy. We’re not just improving how the drug is delivered; we’re improving patients’ lives.”
Prof. Garg says the technology could also be adapted for other chronic conditions such as cancer, diabetes, neurodegenerative disorders, pain management, and chronic infections that require long-term drug delivery.
The system can be tuned to release drugs over a period ranging from a few days to several weeks depending on therapeutic needs.
UniSA scientists hope to start clinical trials in the near future and are exploring commercialisation opportunities.
Nakmode, D. D., et al. (2025). Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson’s disease. Drug Delivery and Translational Research. doi.org/10.1007/s13346-025-01892-y.
News
20-Year Study Finds Daily Multivitamins Don’t Extend Lifespan
A large, decades-long study of over 390,000 U.S. adults challenges a widespread assumption about daily multivitamins. Multivitamins are a daily habit for millions of Americans, often taken with the expectation that they will extend [...]
Novel Investment Paradigms for Regenerative Healthcare Ecosystems
Introduction The transition toward regenerative healthcare ecosystems—anchored in wellness optimization, disease prevention, eradication strategies, and healthy longevity—necessitates a structural reconfiguration of capital architectures, governance models, and incentive design. Regenerative healthcare, by definition, transcends episodic [...]
What If Consciousness Exists Beyond Your Brain
Scientists still don’t know how consciousness emerges from the brain. New ideas suggest it may not emerge at all, but instead be a basic feature of reality. Is consciousness produced by the brain, or [...]
Scientists Discover Way To Treat Lung Cancer and Its Deadly Side Effect Together
A new approach using lipid nanoparticles to deliver genetic material is showing promise in tackling two major challenges in lung cancer at once.Researchers at Oregon State University have designed a new way to tackle two of [...]
Saunas Activate Your Immune System
A brief sauna session may quietly mobilize the immune system. A sauna session may do more than raise your heart rate and body temperature. A new study from Finland found that it also briefly [...]
Why music from your youth still has such an intense effect years later: A psychological perspective
You're driving, and suddenly a familiar song fills the air. Before you even know it, a wave of emotions comes over you – not just memories, but a deep, almost physical feeling. This powerful [...]
AI to antibody in days: breaking the wet lab bottleneck via high-throughput integration
The role of artificial intelligence (AI) in drug design has fundamentally shifted from a speculative tool to a central pillar of pharmaceutical research and development (R&D). Sino Biological plays a critical role in this [...]
Regenerative Healthcare by Design: Engineering Health-Centric Buildings and Urban Ecosystems
Introduction The next evolution of healthcare will not be confined to hospitals, clinics, or episodic interventions—it will be embedded into the infrastructure of everyday life. Regenerative health ecosystems require a systemic re-architecture of how [...]
Scientists Warn: Humanity Has Pushed the Planet Past Its Limits
Human population and consumption have surpassed Earth’s limits, increasing risks to climate and global stability. The Earth is already operating beyond its capacity to sustainably support the global population, according to new research highlighting [...]
Breakthrough Study Reveals Why Damaged Nerves Struggle To Heal
A newly identified molecular mechanism reveals how neurons weigh survival against repair after injury. Scientists at the Icahn School of Medicine at Mount Sinai have identified a molecular switch in neurons that limits the regrowth of [...]
Popular Vitamin B3 Supplements May Help Cancer Cells Survive, Scientists Warn
A new study raises important questions about widely used NAD+ supplements, suggesting that compounds often taken to boost energy and support healthy aging may have unintended consequences in cancer treatment. Millions of Americans take [...]
Scientists Discover Cancer Tumors Are “Addicted” to This Common Antioxidant
Cancer cells may be exploiting a common antioxidant as fuel, revealing a potential weakness that future therapies could target. Cancer cells may be tapping into an unexpected energy source: an antioxidant long associated with [...]
Nanotube injector transfers cytoplasmic contents and organelles between living cells safely
Cells are not isolated units; they continuously exchange proteins, genetic material, and even entire organelles with their neighbors. Intercellular transfer influences how tissues develop, respond to stress, and repair damage. In certain cancers, for [...]
CEO of America’s largest public hospital system is ready to replace radiologists with AI
The chief executive of America’s largest public hospital system says he is prepared to start replacing radiologists with artificial intelligence in some circumstances, once the regulatory landscape catches up. Mitchell H. Katz, MD, president [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Study finds higher heart disease risk in long COVID patients
People with long COVID are at increased risk of developing cardiovascular disease, according to a new study from Karolinska Institutet published in eClinicalMedicine. The results show that the risk of conditions such as cardiac arrhythmias [...]
